Business Description
ATAI Life Sciences NV
ISIN : NL0015000DX5
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.37 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -1.27 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 27.6 | |||||
3-Year EPS without NRI Growth Rate | 14.9 | |||||
3-Year FCF Growth Rate | -57.7 | |||||
3-Year Book Growth Rate | 34.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.31 | |||||
9-Day RSI | 52.72 | |||||
14-Day RSI | 51.89 | |||||
6-1 Month Momentum % | 90.1 | |||||
12-1 Month Momentum % | 17.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.22 | |||||
Quick Ratio | 9.22 | |||||
Cash Ratio | 8.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3 | |||||
Shareholder Yield % | -2.73 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -39180.26 | |||||
Net Margin % | -12810.51 | |||||
FCF Margin % | -26808.87 | |||||
ROE % | -16.49 | |||||
ROA % | -13.95 | |||||
ROIC % | -252.17 | |||||
ROC (Joel Greenblatt) % | -1724.41 | |||||
ROCE % | -13.63 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2050 | |||||
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 1.47 | |||||
EV-to-EBIT | -4.26 | |||||
EV-to-Forward-EBIT | -0.86 | |||||
EV-to-EBITDA | -4.29 | |||||
EV-to-Forward-EBITDA | -1.3 | |||||
EV-to-Revenue | 496.2 | |||||
EV-to-Forward-Revenue | 208.39 | |||||
EV-to-FCF | -2.16 | |||||
Price-to-Net-Current-Asset-Value | 2.64 | |||||
Price-to-Net-Cash | 2.75 | |||||
Earnings Yield (Greenblatt) % | -23.5 | |||||
FCF Yield % | -26.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ATAI Life Sciences NV Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.293 | ||
EPS (TTM) (€) | -0.257 | ||
Beta | 0 | ||
Volatility % | 61.94 | ||
14-Day RSI | 51.89 | ||
14-Day ATR (€) | 0.116651 | ||
20-Day SMA (€) | 1.900475 | ||
12-1 Month Momentum % | 17.39 | ||
52-Week Range (€) | 0.9434 - 2.475 | ||
Shares Outstanding (Mil) | 167.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ATAI Life Sciences NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ATAI Life Sciences NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
ATAI Life Sciences NV Frequently Asked Questions
What is ATAI Life Sciences NV(FRA:9VC)'s stock price today?
When is next earnings date of ATAI Life Sciences NV(FRA:9VC)?
Does ATAI Life Sciences NV(FRA:9VC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |